feed,title,long_url,short_url
Benzinga,"Biogen, Bio-Thera's Biosimilar Referencing Tocilizumab Meets Primary Endpoints In Late-Stage Study",https://benzinga.com/general/biotech/21/06/21369004/biogen-bio-theras-biosimilar-referencing-tocilizumab-meets-primary-endpoints-in-late-stage-study,https://j.mp/2RaqdR4
Benzinga,Credefi - Mitigating The Risks Of Investing In DeFi,https://benzinga.com/markets/cryptocurrency/21/06/21372697/credefi-mitigating-the-risks-of-investing-in-defi,https://j.mp/3pbIoCz
Benzinga,"Corbus In-Licenses Two Anti-Integrin Antibodies Targeting Cancer, Fibrotic Diseases Settings",https://benzinga.com/general/biotech/21/06/21368758/corbus-in-licenses-two-anti-integrin-antibodies-targeting-cancer-fibrotic-diseases-settings,https://j.mp/3uFmzwq
